Agilent Technologies, Inc.: Form 10-Q for the period ended Jan 31, 2013
Filed with the SEC on Mar 6, 2013 and accepted by EDGAR at Mar 5, 2013, 20:37 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-11-01 to 2013-01-31 | $1.68bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2012-11-01 to 2013-01-31 | $800.0m | us-gaap:CostOfRevenue |
| Research and development | 3 months2012-11-01 to 2013-01-31 | $179.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2012-11-01 to 2013-01-31 | $484.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-11-01 to 2013-01-31 | $217.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2012-11-01 to 2013-01-31 | $25.0m | us-gaap:InterestExpense |
| Income tax | 3 months2012-11-01 to 2013-01-31 | $16.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-11-01 to 2013-01-31 | $179.0m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2012-11-01 to 2013-01-31 | $0.51 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-11-01 to 2013-01-31 | $0.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-11-01 to 2013-01-31 | 352,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2012-11-01 to 2013-01-31 | $245.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2012-11-01 to 2013-01-31 | $59.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2012-11-01 to 2013-01-31 | $79.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2013-01-31 | $2.45bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-01-31 | $4.71bn | us-gaap:AssetsCurrent |
| Total assets | At period end2013-01-31 | $10.65bn | us-gaap:Assets |
| Current liabilities | At period end2013-01-31 | $1.85bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-01-31 | $5.30bn | us-gaap:Liabilities |
| Long-term debt | At period end2013-01-31 | $2.11bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2013-01-31 | $250.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2013-01-31 | $5.35bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2013-01-31 | 347,159,281 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001090872-13-000005. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.